KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $3.5 billion.

  • Cme Group's Net Income towards Common Stockholders fell 0.52% to $896.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 8.61%. This contributed to the annual value of $3.5 billion for FY2024, which is 9.29% up from last year.
  • According to the latest figures from FY2024, Cme Group's Net Income towards Common Stockholders is $3.5 billion, which was up 9.29% from $3.2 billion recorded in FY2023.
  • Over the past 5 years, Cme Group's Net Income towards Common Stockholders peaked at $3.5 billion during FY2024, and registered a low of $2.1 billion during FY2020.
  • Its 3-year average for Net Income towards Common Stockholders is $3.1 billion, with a median of $3.2 billion in 2023.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first fell by 0.53% in 2020, then climbed by 24.32% in 2021.
  • Yearly analysis of 5 years shows Cme Group's Net Income towards Common Stockholders stood at $2.1 billion in 2020, then increased by 24.32% to $2.6 billion in 2021, then increased by 1.53% to $2.7 billion in 2022, then rose by 19.89% to $3.2 billion in 2023, then rose by 9.29% to $3.5 billion in 2024.